Home›Search›Neurodegenerative Disease Management

Neurodegenerative Disease Management

Taylor and Francis Ltd. · United Kingdom · Est. 1974

ISSN1758-2024eISSN1758-2032

SJR Q2✓ WOS ESCI✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.804

H-Indexi

SNIPi

0.728

Total Worksi

852

Total Citationsi

10,482

2yr Mean Citednessi

1.38

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Neurodegenerative Disease Management presents findings, analysis, and commentary on neurodegenerative diseases. The journal provides guidance to the multidisciplinary disease management community regarding effective treatment strategies, emerging research, and multidisciplinary approaches, covering topics from disease mechanisms.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1974

FrequencySix No. A Year

StatusActive (last: 2026)

Total Publications852

Publisher OrgFuture Medicine

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1758-2024 / 1758-2032

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

536

2019

841

2020

523

2021

492

2022

162

2023

156

2024

129

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

Neurology (clinical)Q2

Subject Classification

Web of Science Categories

Clinical Neurology

Scopus Categories

Neurology (clinical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Parkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research StudiesDementia and Cognitive Impairment ResearchNeurological disorders and treatmentsAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesPeripheral Neuropathies and DisordersCholinesterase and Neurodegenerative DiseasesNeurogenetic and Muscular Disorders Research

Frequently asked questions about Neurodegenerative Disease Management

Is Neurodegenerative Disease Management a predatory journal?

PubScope has no integrity flags on record for Neurodegenerative Disease Management: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Neurodegenerative Disease Management?

Neurodegenerative Disease Management is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.38.

Is Neurodegenerative Disease Management indexed in Scopus and Web of Science?

Neurodegenerative Disease Management is indexed in Web of Science, Scopus.